Mehiläinen’s year 2025
2025 was a year of strong international growth and significant new openings for Mehiläinen. The company expanded into three new countries, while continuing profitable growth across all business areas.
Mehiläinen’s revenue for 2025 increased by 16.9% from the previous year to EUR 2,413.2 (2,063.5) million. Growth was strong in all operating countries and across different business areas. In the first half of the year, Mehiläinen expanded into Lithuania with the acquisition of InMedica Group, and by the end of the year, acquisitions were concluded for leading healthcare companies Regina Maria in Romania and MediGroup in Serbia. By the end of the year, Mehiläinen had a total of more than 55,000 professionals in seven countries.
Mehiläinen also systematically advanced its sustainability work during the year. The company published a new sustainability program that sets targets for 2030. These targets focus on Mehiläinen's most essential sustainability aspects: investments in high-quality care, climate-resilient social and healthcare, a thriving diverse community, as well as sustainable, secure business operations.
Learn more about Mehiläinen's year 2025 through our Annual Report.
Annual Report
The Annual Report covers the year's key developments, Sustainability Report, as well as Financial Statements and the Board of Directors' Report. This is Mehiläinen's first Sustainability Report, which applies the European Sustainability Reporting Standards (ESRS).
Overview of the results and the year 2025
Watch the video to see Mehiläinen Group's CEO Janne-Olli Järvenpää's thoughts about the past year.